Clinical and Angiographic Outcomes With a Novel Radiopaque Sirolimus-Eluting Bioresorbable Vascular Scaffold

Bioresorbable stents: Current and upcoming bioresorbable technologies

(2017) Hui Ying Ang et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

6-Month Clinical and Angiographic Outcomes of a Novel Radiopaque Sirolimus-Eluting Bioresorbable Vascular Scaffold

(2017) Alexandre Abizaid et al.   JACC-Cardiovascular Interventions

Three-Year Outcomes With the Absorb Bioresorbable Scaffold

(2017) Ziad A. Ali et al.   CIRCULATION

Serial Multimodality Imaging and 2-Year Clinical Outcomes of the Novel DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold System for the Treatment of Single De Novo Coronary Lesions

(2016) Alexandre Abizaid et al.   JACC-Cardiovascular Interventions

Vasomotor Function Comparative Assessment at 1 and 2 Years Following Implantation of the Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold and the Xience V Everolimus-Eluting Metallic Stent in Porcine Coronary Arteries

(2016) Bill D. Gogas et al.   JACC-Cardiovascular Interventions

Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial

(2016) Patrick W Serruys et al.   LANCET

Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial

(2016) Michael Haude et al.   LANCET

1-year outcomes with the Absorb bioresorbable scaffold in patients with coronary artery disease: a patient-level, pooled meta-analysis

(2016) Gregg W Stone et al.   LANCET

Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease

(2015) Stephen G. Ellis et al.   NEW ENGLAND JOURNAL OF MEDICINE

Current Status of Bioresorbable Scaffolds in the Treatment of Coronary Artery Disease

(2014) Jens Wiebe et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Comparison of in vivo acute stent recoil between the bioresorbable everolimus-eluting coronary scaffolds (revision 1.0 and 1.1) and the metallic everolimus-eluting stent

(2011) Yoshinobu Onuma et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Stent Thrombogenicity Early in High-Risk Interventional Settings Is Driven by Stent Design and Deployment and Protected by Polymer-Drug Coatings

(2011) Kumaran Kolandaivelu et al.   CIRCULATION

Evaluation of the Second Generation of a Bioresorbable Everolimus Drug-Eluting Vascular Scaffold for Treatment of De Novo Coronary Artery Stenosis

(2010) Patrick W. Serruys et al.   CIRCULATION

A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial

(2008) John A Ormiston et al.   LANCET